This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sunto-gun, JP (2012)
- Mishima, JP (2010 - 2015)
Company Filing History:
Years Active: 2010-2015
Introduction
Masamori Sugawara is a distinguished inventor based in Mishima, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of six patents to his name, he has focused on innovative treatments aimed at addressing various medical conditions.
Latest Patents
Sugawara's latest patents highlight his expertise in the development of compounds with therapeutic effects. One notable invention is a ring-fused heterocyclic derivative, which is represented by a specific general formula. This compound exhibits a T-type calcium channel regulatory effect, making it useful as a therapeutic and preventive agent against pruritus. Another significant patent involves thiazole derivatives, which provide methods for treating central nervous system diseases, showcasing his commitment to advancing medical science.
Career Highlights
Masamori Sugawara works for Kyowa Hakko Kirin Co., Limited, where he has made substantial contributions to pharmaceutical research and development. His innovative work in the field has not only resulted in patents but has also inspired new approaches to the treatment of complex medical conditions.
Collaborations
Throughout his career, Sugawara has collaborated with esteemed colleagues, including Noriaki Uesaka and Yoshisuke Nakasato. These partnerships have likely facilitated the exchange of ideas and expertise, contributing to the successful development of his patented inventions.
Conclusion
Masamori Sugawara exemplifies the spirit of innovation within the pharmaceutical industry. With his ongoing contributions and multiple patents, he continues to play a pivotal role in the advancement of therapeutic solutions, positively impacting patient care and medical outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
